Skip to main content
 

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

AHA Innovators’ Network Member Biobeat’s RPM Devices and Platform Receive FDA Clearances for Stroke Volume and Cardiac Output

Innovators’ Network member company Biobeat, announced that its wearable remote patient monitoring devices have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to monitor stroke volume and cardiac output in addition to cuffless blood pressure, blood oxygen saturation, pulse rate, respiratory rate and body temperature. Read more here.

More News

  • Cardiac Rehabilitation Enabled With Health Technology: Innovative Models of Care Delivery and Policy to Enhance Health Equity

    Cardiac rehabilitation (CR) is a well‐established program for secondary prevention of cardiovascular…

  • Century of progress sets stage for future scientific advances in cardiovascular health

    Dramatic advances in the understanding and treatment of cardiovascular diseases have saved millions of…

  • Cardiovascular care centered on the patient is key and helps improve equity and outcomes

    Patient-centered care establishes a respectful partnership among the health care team, the…

  • Upcoming Webinar: Heart Talks: Navigating Vascular Aging for Heart Health 5/23!

    The CHTI is please to convene this group of experts on an…

Sign up for our mailing list